Literature DB >> 18334605

Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans.

Juris J Meier1, Alexandra E Butler, Yoshifumi Saisho, Travis Monchamp, Ryan Galasso, Anil Bhushan, Robert A Rizza, Peter C Butler.   

Abstract

OBJECTIVE: Little is known about the capacity, mechanisms, or timing of growth in beta-cell mass in humans. We sought to establish if the predominant expansion of beta-cell mass in humans occurs in early childhood and if, as in rodents, this coincides with relatively abundant beta-cell replication. We also sought to establish if there is a secondary growth in beta-cell mass coincident with the accelerated somatic growth in adolescence. RESEARCH DESIGN AND METHODS: To address these questions, pancreas volume was determined from abdominal computer tomographies in 135 children aged 4 weeks to 20 years, and morphometric analyses were performed in human pancreatic tissue obtained at autopsy from 46 children aged 2 weeks to 21 years.
RESULTS: We report that 1) beta-cell mass expands by severalfold from birth to adulthood, 2) islets grow in size rather than in number during this transition, 3) the relative rate of beta-cell growth is highest in infancy and gradually declines thereafter to adulthood with no secondary accelerated growth phase during adolescence, 4) beta-cell mass (and presumably growth) is highly variable between individuals, and 5) a high rate of beta-cell replication is coincident with the major postnatal expansion of beta-cell mass.
CONCLUSIONS: These data imply that regulation of beta-cell replication during infancy plays a major role in beta-cell mass in adult humans.

Entities:  

Mesh:

Year:  2008        PMID: 18334605      PMCID: PMC3697779          DOI: 10.2337/db07-1369

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  36 in total

Review 1.  Pancreas and islet transplantation for patients with diabetes.

Authors:  R P Robertson; C Davis; J Larsen; R Stratta; D E Sutherland
Journal:  Diabetes Care       Date:  2000-01       Impact factor: 19.112

2.  Relationship between beta-cell mass and fasting blood glucose concentration in humans.

Authors:  Robert A Ritzel; Alexandra E Butler; Robert A Rizza; Johannes D Veldhuis; Peter C Butler
Journal:  Diabetes Care       Date:  2006-03       Impact factor: 19.112

3.  Birth weight and subsequent risk of type 2 diabetes: a meta-analysis.

Authors:  Thomas Harder; Elke Rodekamp; Karen Schellong; Joachim W Dudenhausen; Andreas Plagemann
Journal:  Am J Epidemiol       Date:  2007-01-10       Impact factor: 4.897

4.  Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

Authors:  J J Meier; A Bhushan; A E Butler; R A Rizza; P C Butler
Journal:  Diabetologia       Date:  2005-10-05       Impact factor: 10.122

5.  Beta-cell deficit due to increased apoptosis in the human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes.

Authors:  Aleksey V Matveyenko; Peter C Butler
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

6.  Increased islet beta cell replication adjacent to intrapancreatic gastrinomas in humans.

Authors:  J J Meier; A E Butler; R Galasso; R A Rizza; P C Butler
Journal:  Diabetologia       Date:  2006-09-23       Impact factor: 10.122

7.  Hematopoietic stem cells derived from adult donors are not a source of pancreatic beta-cells in adult nondiabetic humans.

Authors:  Alexandra E Butler; Andrew Huang; P Nagesh Rao; Anil Bhushan; William J Hogan; Robert A Rizza; Peter C Butler
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

Review 8.  The potential for stem cell therapy in diabetes.

Authors:  Juris J Meier; Anil Bhushan; Peter C Butler
Journal:  Pediatr Res       Date:  2006-04       Impact factor: 3.756

9.  Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes.

Authors:  Y Saisho; A E Butler; J J Meier; T Monchamp; M Allen-Auerbach; R A Rizza; P C Butler
Journal:  Clin Anat       Date:  2007-11       Impact factor: 2.414

10.  Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes.

Authors:  Eleftheria Zeggini; Michael N Weedon; Cecilia M Lindgren; Timothy M Frayling; Katherine S Elliott; Hana Lango; Nicholas J Timpson; John R B Perry; Nigel W Rayner; Rachel M Freathy; Jeffrey C Barrett; Beverley Shields; Andrew P Morris; Sian Ellard; Christopher J Groves; Lorna W Harries; Jonathan L Marchini; Katharine R Owen; Beatrice Knight; Lon R Cardon; Mark Walker; Graham A Hitman; Andrew D Morris; Alex S F Doney; Mark I McCarthy; Andrew T Hattersley
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

View more
  342 in total

1.  Staining protocols for human pancreatic islets.

Authors:  Martha L Campbell-Thompson; Tiffany Heiple; Emily Montgomery; Li Zhang; Lynda Schneider
Journal:  J Vis Exp       Date:  2012-05-23       Impact factor: 1.355

2.  Clinical trials in youth with type 2 diabetes.

Authors:  Julie Anne L Gemmill; Rebecca J Brown; Radha Nandagopal; Luisa M Rodriguez; Kristina I Rother
Journal:  Pediatr Diabetes       Date:  2011-02       Impact factor: 4.866

3.  Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes.

Authors:  A Willcox; S J Richardson; A J Bone; A K Foulis; N G Morgan
Journal:  Diabetologia       Date:  2010-06-09       Impact factor: 10.122

Review 4.  Understanding pancreas development for β-cell repair and replacement therapies.

Authors:  Aurelia Raducanu; Heiko Lickert
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

5.  Insulin secretion and insulin-producing tumors.

Authors:  Jean-Marc Guettier; Phillip Gorden
Journal:  Expert Rev Endocrinol Metab       Date:  2010-03-01

6.  Human beta cell proliferation by glucose--a complex scenario.

Authors:  M Tiedge
Journal:  Diabetologia       Date:  2010-12-21       Impact factor: 10.122

Review 7.  Epigenetic regulation of pancreas development and function.

Authors:  Dana Avrahami; Klaus H Kaestner
Journal:  Semin Cell Dev Biol       Date:  2012-06-21       Impact factor: 7.727

Review 8.  Targeting the pancreatic β-cell to treat diabetes.

Authors:  Amedeo Vetere; Amit Choudhary; Sean M Burns; Bridget K Wagner
Journal:  Nat Rev Drug Discov       Date:  2014-02-14       Impact factor: 84.694

9.  Targeting the cell cycle inhibitor p57Kip2 promotes adult human β cell replication.

Authors:  Dana Avrahami; Changhong Li; Ming Yu; Yang Jiao; Jia Zhang; Ali Naji; Seyed Ziaie; Benjamin Glaser; Klaus H Kaestner
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

Review 10.  Advances in β cell replacement and regeneration strategies for treating diabetes.

Authors:  Jacqueline R Benthuysen; Andrea C Carrano; Maike Sander
Journal:  J Clin Invest       Date:  2016-10-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.